Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets.
[dedifferentiated liposarcoma]
Dedifferentiated
liposarcoma
(
DDLS
)
is
a
rare
but
aggressive
cancer
with
high
recurrence
and
low
response
rates
to
targeted
therapies
.
Increasing
treatment
efficacy
may
require
combinations
of
targeted
agents
that
counteract
the
effects
of
multiple
abnormalities
.
To
identify
a
possible
multicomponent
therapy
,
we
performed
a
combinatorial
drug
screen
in
a
DDLS
-derived
cell
line
and
identified
cyclin-dependent
kinase
4
(
CDK
4
)
and
insulin-like
growth
factor
1
receptor
(
IGF
1
R
)
as
synergistic
drug
targets
.
We
measured
the
phosphorylation
of
multiple
proteins
and
cell
viability
in
response
to
systematic
drug
combinations
and
derived
computational
models
of
the
signaling
network
.
These
models
predict
that
the
observed
synergy
in
reducing
cell
viability
with
CDK
4
and
IGF
1
R
inhibitors
depends
on
the
activity
of
the
AKT
pathway
.
Experiments
confirmed
that
combined
inhibition
of
CDK
4
and
IGF
1
R
cooperatively
suppresses
the
activation
of
proteins
within
the
AKT
pathway
.
Consistent
with
these
findings
,
synergistic
reductions
in
cell
viability
were
also
found
when
combining
CDK
4
inhibition
with
inhibition
of
either
AKT
or
epidermal
growth
factor
receptor
(
EGFR
)
,
another
receptor
similar
to
IGF
1
R
that
activates
AKT
.
Thus
,
network
models
derived
from
context-
specific
proteomic
measurements
of
systematically
perturbed
cancer
cells
may
reveal
cancer
-
specific
signaling
mechanisms
and
aid
in
the
design
of
effective
combination
therapies
.
Diseases
Validation
Diseases presenting
"growth factor receptor"
symptom
achondroplasia
aromatase deficiency
cholangiocarcinoma
dedifferentiated liposarcoma
esophageal adenocarcinoma
esophageal carcinoma
esophageal squamous cell carcinoma
kallmann syndrome
lymphangioleiomyomatosis
oral submucous fibrosis
proteus syndrome
severe combined immunodeficiency
wiskott-aldrich syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom